Gene: DEPTOR
Official Full Name: DEP domain containing MTOR interacting proteinprovided by HGNC
Gene Summary: Enables phosphatidic acid binding activity and protein serine/threonine kinase inhibitor activity. Involved in several processes, including negative regulation of TOR signaling; negative regulation of cell size; and negative regulation of protein kinase activity. Is active in lysosomal membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO09162 | DEPTOR Knockout cell line (HeLa) | Human | DEPTOR | 1:3~1:6 | Negative | Online Inquiry |
KO09163 | DEPTOR Knockout cell line (HCT 116) | Human | DEPTOR | 1:2~1:4 | Negative | Online Inquiry |
KO09164 | DEPTOR Knockout cell line (HEK293) | Human | DEPTOR | 1:3~1:6 | Negative | Online Inquiry |
KO09165 | DEPTOR Knockout cell line (A549) | Human | DEPTOR | 1:3~1:4 | Negative | Online Inquiry |
DEPTOR Gene Knockout Cell Lines are genetically engineered cell lines that have been specifically modified to lack the functional expression of the DEPTOR gene, which encodes a key regulator of the mTOR signaling pathway. DEPTOR functions primarily as an inhibitor of the mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2), both of which play crucial roles in cell growth, proliferation, and survival. By utilizing these knockout cell lines, researchers can investigate the downstream effects of DEPTOR loss on cellular metabolism, differentiation, and apoptosis, enabling a deeper understanding of its broader implications in cancer, metabolic disorders, and neurological conditions.
The key function of DEPTOR Gene Knockout Cell Lines lies in their ability to facilitate the exploration of mTOR pathway deregulation, a common feature in various malignancies. When the DEPTOR gene is knocked out, the consequent increase in mTOR activity can be closely studied, revealing critical insights into the cellular responses to nutrients, growth factors, and stressors. This makes these cell lines invaluable tools for drug discovery, as they are instrumental in screening potential mTOR inhibitors and other therapeutic compounds.
Scientifically, DEPTOR Gene Knockout Cell Lines have applications across multiple research domains, including cancer biology, neurobiology, and metabolic research, potentially leading to novel therapeutic strategies. Compared to alternative methods such as RNA interference or CRISPR/Cas9 systems, these knockout models provide a stable and homogeneous genetic background, ensuring reproducibility in experimental outcomes and minimizing off-target effects.
Researchers and clinicians will find value in these cell lines as they offer a targeted approach to dissecting the specific contributions of DEPTOR to cellular processes, thus paving the way for innovative therapeutic interventions. Furthermore, our commitment to quality and reliability in scientific research is underscored by our rigorous validation and production processes, making DEPTOR Gene Knockout Cell Lines a trusted resource for advancing biological research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.